Oral Ketoconazole HRA Recommended for Approval for Cushing's Syndrome

Here is some hope for people of the European Union suffering from Cushing's syndrome who cannot undergo surgery. The European Medicines Agency has recommended the approval for the use of a drug Ketoconazole HRA, which contains the active ingredient ketoconazole, for the use in Cushing's syndrome. Cushing's Syndrome Treatment: Cushing's syndrome is a hormonal disorder where there is excess of the hormone cortisol in the body. The condition ...

Read More
You have just read an article categorized health titled Oral Ketoconazole HRA Recommended for Approval for Cushing's Syndrome.
Written by: editor - Tuesday, September 30, 2014

There are currently no comments for "Oral Ketoconazole HRA Recommended for Approval for Cushing's Syndrome"

Post a Comment